"Dear hair loss"-illness perceptions of female patients with chemotherapy-induced alopecia.
Chemotherapy-induced alopecia
Common Sense Model
Coping
Illness perceptions
Psychological impact
Quality of life
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
05
08
2021
accepted:
07
12
2021
pubmed:
21
1
2022
medline:
26
3
2022
entrez:
20
1
2022
Statut:
ppublish
Résumé
Chemotherapy-induced alopecia (CIA) is one of the most common and distressing side effects of chemotherapy treatment. This study aims to assess the illness perceptions of female patients dealing with CIA, and their associations with demographic and clinical characteristics, coping strategies, and quality of life. The secondary aim was to compare the illness perceptions of patients with CIA with other samples, to help elucidate the specific perceptions of patients with CIA. Forty female patients at risk of severe hair loss due to chemotherapy treatment were included at the oncological daycare unit of a teaching hospital in the Netherlands. Patients were asked to complete the Brief-Illness Perception Questionnaire (B-IPQ) and the Hair Quality of Life (Hair-QoL) questionnaire. Illness perceptions indicated that although patients understood their hair loss, they lacked being able to make sense of managing it, negatively impacting patients' lives. Psychological quality of life was significantly correlated with the B-IPQ domains: consequences, degree of concern, and emotional response. Social quality of life was significantly correlated with psychological quality of life. Patients with CIA felt significantly less able to manage their hair loss, compared to patients with breast cancer and psoriatic arthritis. As patients' beliefs of being able to manage their hair loss are important for adopting and maintaining adequate coping behaviors, additional effort of health care providers in fostering patients' sense of control is indicated, focusing on patients' strengths during and after chemotherapy treatment. In the context of developing interventions for patients with CIA, consequences, concern, and emotional response are the major dimensions that should be taken in account to help patients deal with hair loss.
Identifiants
pubmed: 35048177
doi: 10.1007/s00520-021-06748-y
pii: 10.1007/s00520-021-06748-y
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3955-3963Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Dua P, Heiland MF, Kracen AC, Deshields TL (2017) Cancer-related hair loss: a selective review of the alopecia research literature. Psycho-Oncol 26(4):438–443. https://doi.org/10.1002/pon.4039
doi: 10.1002/pon.4039
Haque E et al (2020) Management of chemotherapy-induced alopecia (CIA): a comprehensive review and future directions. Crit Rev Oncol Hematol 156:103093–103093. https://doi.org/10.1016/j.critrevonc.2020.103093
doi: 10.1016/j.critrevonc.2020.103093
pubmed: 33070077
Chon SY, Champion RW, Geddes ER, Rashid RM (2011) Chemotherapy-induced alopecia. J Am Acad Dermatol 67(1):e37–e47. https://doi.org/10.1016/j.jaad.2011.02.026
doi: 10.1016/j.jaad.2011.02.026
pubmed: 22178150
Kim I-R et al Perception, attitudes, preparedness and experience of chemotherapy-induced alopecia among breast cancer patients: a qualitative study. Asian Pac J Cancer prev 13(4): 1383–1388. https://doi.org/10.7314/apjcp.2012.13.4.1383
Borsellino M, Young MM (2011) Anticipatory coping: taking control of hair loss. Clin J Oncol Nurs 15(3):311–315. https://doi.org/10.1188/11.CJON.311-315
doi: 10.1188/11.CJON.311-315
pubmed: 21624866
Lemieux J, Maunsell E, Provencher L (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho-Oncol 17(4):317–328. https://doi.org/10.1002/pon.1245
doi: 10.1002/pon.1245
Trusson D, Pilnick A (2017) The role of hair loss in cancer identity: perceptions of chemotherapy-induced alopecia among women treated for early-stage breast cancer or ductal carcinoma in situ. Cancer Nurs 40(2):E9–E16. https://doi.org/10.1097/NCC.0000000000000373
doi: 10.1097/NCC.0000000000000373
pubmed: 27070222
Trüeb RM (2010) Chemotherapy-induced alopecia. Curr Opin Support Palliat Care 4(4):281–284. https://doi.org/10.1097/SPC.0b013e3283409280
doi: 10.1097/SPC.0b013e3283409280
pubmed: 21045702
Choi EK et al (2014) Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psycho-Oncol 23(10):1103–1110. https://doi.org/10.1002/pon.3531
doi: 10.1002/pon.3531
Yeager CE, Olsen EA (2011) Treatment of chemotherapy-induced alopecia. Dermatol Ther 24(4):432–442. https://doi.org/10.1111/j.1529-8019.2011.01430.x
doi: 10.1111/j.1529-8019.2011.01430.x
pubmed: 21910801
Leventhal H, Philips LA, Burns E (2016) The Common-Sense Model of Self-Regulation (CSM): a dynamic framework for understanding illness self-management. J Behav Med 39(6):935–946. https://doi.org/10.1007/s10865-016-9782-2
doi: 10.1007/s10865-016-9782-2
pubmed: 27515801
Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V (2013) Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS ONE 8(12):e80633. https://doi.org/10.1371/journal.pone.0080633
doi: 10.1371/journal.pone.0080633
pubmed: 24312488
pmcid: 3846635
Broadbent E, Wilkes C, Koschwanez H, Weinman J, Norton S, Petrie KJ (2015) A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychol Health 30(11):1361–1385. https://doi.org/10.1080/08870446.2015.1070851
doi: 10.1080/08870446.2015.1070851
pubmed: 26181764
Richardson AE, Tennant G, Morton RP, Broadbent E (2017) A self-regulatory intervention for patients with head and neck cancer: pilot randomized trial. Ann Behav Med 51(5):629–641. https://doi.org/10.1007/s12160-017-9885-1
doi: 10.1007/s12160-017-9885-1
pubmed: 28244003
Mulders M, Vingerhoets A, Breed W (2008) The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs 12(2):97–102. https://doi.org/10.1016/j.ejon.2007.10.002
doi: 10.1016/j.ejon.2007.10.002
pubmed: 18242139
Paterson C et al (2021) Identifying the supportive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review J Cancer Surviv 15(1):14–28. https://doi.org/10.1007/s11764-020-00907-6
doi: 10.1007/s11764-020-00907-6
pubmed: 32683651
Coolbrandt A et al (2021) Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results. Breast Cancer Res Treat 186(3):715–722. https://doi.org/10.1007/s10549-020-06063-w
doi: 10.1007/s10549-020-06063-w
pubmed: 33452953
Shaw JM et al (2018) Barriers and enablers to implementing scalp cooling in Australia: a qualitative study of health professionals’ attitudes to and experience with scalp cooling. Support Care Cancer 26(1):305–312. https://doi.org/10.1007/s00520-017-3849-7
doi: 10.1007/s00520-017-3849-7
pubmed: 28852873
Smith K, Winstanley J, Boyle F, O’Reilly A, White M, Antill YC (2018) Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy. Support Care Cancer 26(2):483–489. https://doi.org/10.1007/s00520-017-3852-z
doi: 10.1007/s00520-017-3852-z
pubmed: 28831569
Shin H, Jo SJ, Kim DH, Kwon O, Myung S-K (2015) Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer 136(5):E442–E454. https://doi.org/10.1002/ijc.29115
doi: 10.1002/ijc.29115
pubmed: 25081068
Rugo HS, Voigt J (2018) Scalp hypothermia for preventing alopecia during chemotherapy. A systematic review and meta-analysis of randomized controlled trials. Clin Breast Cancer 18(1):19–28. https://doi.org/10.1016/j.clbc.2017.07.012
doi: 10.1016/j.clbc.2017.07.012
pubmed: 28939291
Shah VV et al (2018) Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials. J Eur Acad Dermatol Venereol 32(5):720–734. https://doi.org/10.1111/jdv.14612
doi: 10.1111/jdv.14612
pubmed: 28976026
Van den Hurk CJG, Mols F, Vingerhoets AJJM, Breed WPM (2010) Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psycho Oncol 19(7):701–709. https://doi.org/10.1002/pon.1615
doi: 10.1002/pon.1615
van Alphen K, Versluis A, Dercksen W, de Haas H, Lugtenberg R, Tiemensma J, Kroep J, Broadbent E, Kaptein AA, van den Hurk C (2020) Giving a face to chemotherapy-induced alopecia: a feasibility study on drawings by patients. Asia Pac J Oncol Nurs 7(2):218–224. https://doi.org/10.4103/apjon.apjon_8_20
doi: 10.4103/apjon.apjon_8_20
pubmed: 32478141
pmcid: 7233558
Marks DH et al (2019) The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. Breast Cancer Res Treat 175(2):267–276. https://doi.org/10.1007/s10549-019-05169-0
doi: 10.1007/s10549-019-05169-0
pubmed: 30806923
Zannini L, Verderame F, Cucchiara G, Zinna B, Alba A, Ferrara M (2012) ‘My wig has been my journey’s companion’: perceived effects of an aesthetic care programme for Italian women suffering from chemotherapy-induced alopecia. Eur J Cancer Care 21(5):650–660. https://doi.org/10.1111/j.1365-2354.2012.01337.x
doi: 10.1111/j.1365-2354.2012.01337.x
Iliffe LL, Thompson AR (2019) Investigating the beneficial experiences of online peer support for those affected by alopecia: an interpretative phenomenological analysis using online interviews. Br J Dermatol 181(5):992–998. https://doi.org/10.1111/bjd.17998
doi: 10.1111/bjd.17998
pubmed: 30972732
pmcid: 6899973
McGarvey EL et al (2010) An evaluation of a computer-imaging program to prepare women for chemotherapy-related alopecia. Psycho Oncol 19(7):756–766. https://doi.org/10.1002/pon.1637
doi: 10.1002/pon.1637
Boland V, Brady AM, Drury A (2020) The physical, psychological and social experiences of alopecia among women receiving chemotherapy: an integrative literature review. Eur J Oncol Nurs 49:101840–101840. https://doi.org/10.1016/j.ejon.2020.101840
doi: 10.1016/j.ejon.2020.101840
pubmed: 33120213
Petrie K, Weinman J (2006) Why illness perceptions matter. Clin Med 6(6):536–539. https://doi.org/10.7861/clinmedicine.6-6-536
doi: 10.7861/clinmedicine.6-6-536
Komen MMC, Smorenburg CH, Nortier JWR, van der Ploeg T, van den Hurk CJG, van der Hoeven JJM (2016) Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature. Breast 30:105–110. https://doi.org/10.1016/j.breast.2016.09.007
doi: 10.1016/j.breast.2016.09.007
pubmed: 27689316
Broadbent E, Petrie KJ, Main J, Weinman J (2006) The Brief Illness Perception Questionnaire. J Psychosom Res 60(6):631–637. https://doi.org/10.1016/j.jpsychores.2005.10.020
doi: 10.1016/j.jpsychores.2005.10.020
pubmed: 16731240
Versluis A, van Alphen K, Dercksen W, de Haas H, van den Hurk C, Kaptein AA (in press). Looking bad: patients drawing their representations of chemotherapy-induced alopecia. J Health Psychol
Willemse H, van der Doef M, van Middendorp H (2019) Applying the Common Sense Model to predicting quality of life in alopecia areata: the role of illness perceptions and coping strategies. J Health Psychol 24(11):1461–1472. https://doi.org/10.1177/1359105317752826
doi: 10.1177/1359105317752826
pubmed: 29355049
Kaptein AA et al (2013) Illness perceptions and quality of life in Japanese and Dutch women with breast cancer. J Psychosoc Oncol 31(1):83–102. https://doi.org/10.1080/07347332.2012.741092
doi: 10.1080/07347332.2012.741092
pubmed: 23311973
Kotsis K et al (2012) Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res 64(10):1593–1601. https://doi.org/10.1002/acr.21725
doi: 10.1002/acr.21725
Hagger MS, Orbell S (2021) The common sense model of illness self-regulation: a conceptual review and proposed extended model. Health Psychol Rev 1:1–31. https://doi.org/10.1080/17437199.2021.1878050
doi: 10.1080/17437199.2021.1878050
Hoogerwerf MA, Ninaber MK, Willems LNA, Kaptein AA (2012) “Feelings are facts”: Illness perceptions in patients with lung cancer. Respir Med 106(8):1170–1176. https://doi.org/10.1016/j.rmed.2012.04.006
doi: 10.1016/j.rmed.2012.04.006
pubmed: 22579109
Schoormans D, Wijnberg L, Haak H, Husson O, Mols F (2020) Negative illness perceptions are related to poorer health-related quality of life among thyroid cancer survivors: Results from the PROFILES registry. Head Neck 42(9):2533–2541. https://doi.org/10.1002/hed.26290
doi: 10.1002/hed.26290
pubmed: 32488948
pmcid: 7496500
Bonsaksen T, Lerdal A, Fagermoen MS (2015) Trajectories of illness perceptions in persons with chronic illness: an explorative longitudinal study. J Health Psychol 20(7):942–953. https://doi.org/10.1177/1359105313504235
doi: 10.1177/1359105313504235
pubmed: 24140616
Shaw J et al (2016) Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer. Support Care Cancer 24(9):3813–3820. https://doi.org/10.1007/s00520-016-3206-2
doi: 10.1007/s00520-016-3206-2
pubmed: 27061409
Drageset S, Lindstrøm TC, Giske T, Underlid K (2016) Women’s experiences of social support during the first year following primary breast cancer surgery. Scand J Caring Sci 30(2):340–348. https://doi.org/10.1111/scs.12250
doi: 10.1111/scs.12250
pubmed: 26179112
Van den Hurk C, Keizer-Heldens P, Raats I, Hoeijmakers K, Mols F (2019) Improving information provision on chemotherapy-induced alopecia and scalp cooling: a comprehensive approach including a website and web-based decision tool. Asia Pac J Oncol Nurs 6(4):336–342. https://doi.org/10.4103/apjon.apjon_19_19
doi: 10.4103/apjon.apjon_19_19
pubmed: 31572752
pmcid: 6696804
Deshields TL, Nanna SK (2010) Providing care for the “Whole Patient” in the cancer setting: the psycho-oncology consultation model of patient care. J Clin Psychol Med Settings 17(3):249–257. https://doi.org/10.1007/s10880-010-9208-1
doi: 10.1007/s10880-010-9208-1
pubmed: 20799056